NCT05434689 2026-03-05
COMMANDER
University of Alabama at Birmingham
Phase 1/2 Active not recruiting
Clinical Trials
7 trialsNCT05560399 2026-01-02
CC-220
Icahn School of Medicine at Mount Sinai
Phase EARLY_PHASE1 Active not recruiting
NCT05392946 2025-10-29
Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma, IDEAL Study
Mayo Clinic
Phase 1/2 Active not recruiting
NCT04975997 2025-07-10
EXCALIBER-RRMM
Celgene
Phase 3 Active not recruiting
NCT05177536 2025-05-13
Iberdomide Maintenance Therapy in Patients With Multiple Myeloma
University of Nebraska
Phase 2 Active not recruiting
NCT04998786 2025-04-06
I2D IFM2021_03
Nantes University Hospital
Phase 2 Active not recruiting
NCT04392037 2025-03-28
ICON
Amsterdam UMC, location VUmc
Phase 2 Active not recruiting